MedPath

The effect of saffron supplementation on Parkinson's disease

Phase 3
Conditions
Parkinson's disease.
Parkinson's disease
Registration Number
IRCT20121216011763N61
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
86
Inclusion Criteria

Agreement for participation in the study
Age of 50 to 80 years old
Diagnosis of Parkinson's disease based on United Kingdom PD Society Brain Bank (UKPDSBB) criteria
Having the Hoehn and Yahr score less than 5
BMI equal or less than 35

Exclusion Criteria

Adherence to a specific diet or consumption of antioxidant supplements in the last 3 months
Patients with other neurodegenerative diseases such as Huntington's disease, Wilson's disease
Central nervous system infections such as meningitis
Having a Hoehn and Yahr score of 5 out of 5
Patients with a history of saffron allergy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath